Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole for prevention of NSAID-associated upper GI symptoms
NCT00241514Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Feb 2001
- Primary completion
- Feb 2003
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of esomeprazole, sponsored by AstraZeneca. Started Feb 2001; status: completed.
02
Drugs
esomeprazole
Beyond the preview
Go deeper on NCT00241514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00241514.